SEC registrant · CIK 0001477598

Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. (CIK 0001477598, EIN 26-3797738) reported net income of -$6.25 million (-$6,253,233) for Q1 FY2013 (2013-01-01 to 2013-03-31) and total assets of $18.35 million ($18,346,868) for Q1 FY2013 (as of 2013-03-31), as filed in its 10-Q filed 2013-05-28 (accession 0001104659-13-044952).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31). The company has no annual (10-K) values here; the figures are quarterly.

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.
  • Quarterly operating cash flow is usually reported year to date; such values say so in their period.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001477598
EIN26-3797738
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Entity typeoperating
Olympus entity IDorg_0e47e6at3kw57rvqhmagj4g3xh
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest quarterly financial metrics

The latest quarterly value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Net income-$6,253,233Q1 FY20132013-01-01 to 2013-03-3110-Q2013-05-280001104659-13-044952NetIncomeLoss
Total assets$18,346,868Q1 FY2013as of 2013-03-3110-Q2013-05-280001104659-13-044952Assets
Stockholders' equity-$64,290,082Q1 FY2013as of 2013-03-3110-Q2013-05-280001104659-13-044952StockholdersEquity
Operating cash flow-$3,949,225Q1 FY20132013-01-01 to 2013-03-3110-Q2013-05-280001104659-13-044952NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Diluted earnings per share-$3.08 per shareQ1 FY20132013-01-01 to 2013-03-3110-Q2013-05-280001104659-13-044952EarningsPerShareBasicAndDiluted
Shares outstanding24,414,171 sharesQ1 FY2013as of 2013-05-2410-Q2013-05-280001104659-13-044952EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every quarterly revenue and net income value served for fiscal years 2004-2013, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
Net incomeQ1 FY20132013-01-01 to 2013-03-31-$6,253,23310-Q2013-05-280001104659-13-044952

Recent 10-K and 10-Q filings

All 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2013-05-282013-03-310001104659-13-044952a13-12666_110q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001477598published by the sourcedata.sec.gov/submissions/CIK0001477598.json2026-10-21
Employer Identification Number (EIN) · US-EIN26-3797738published by the sourcedata.sec.gov/submissions/CIK0001477598.json2026-10-21

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001477598.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001477598.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001477598" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001477598/financials?period=quarterly" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001477598/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1477598"}

On SEC EDGAR

About this data